P/E Ratio: Price to Earnings - Most used valuation metric
Analyzing Investment Quality
Processing 9 key metrics...
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Loading shareholding data...
| Insider Name | Transaction Date | Filing Date | Total Shares | Change | Price | Action |
|---|---|---|---|---|---|---|
Vasant Rathi | 24 Mar 2025 | 25 Mar 2025 | 3.71 Cr | 1.50 L | ₹291.05 | BUY |
Atul Biyani | 21 Mar 2025 | 25 Mar 2025 | 7,550 | 3,000 | ₹292.5 | BUY |
Kishor Laxminarayan Rathi | 20 Mar 2025 | 25 Mar 2025 | 4.06 L | 11.00 L | - | SELL |
Kishor Laxminarayan Rathi HUF | 20 Mar 2025 | 25 Mar 2025 | 11.00 L | 11.00 L | - | BUY |
Vasant Rathi | 26 Mar 2025 | 28 Mar 2025 | 3.71 Cr | 25,000 | ₹282.54 | BUY |
Payal Akshay Kulkarni | 25 Mar 2025 | 28 Mar 2025 | 7,500 | 20,000 | - | SELL |
Standard pivot points - most widely used
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹329.88 | +₹36.53 | +12.45% |
| R3 | ₹315.03 | +₹21.68 | +7.39% |
| R2 | ₹307.02 | +₹13.67 | +4.66% |
| R1 | ₹300.18 | +₹6.83 | +2.33% |
| PIVOT | ₹292.17 | -1.18 | -0.40% |
| CURRENT | ₹293.35 | - | - |
| S1 | ₹255.63 | -₹37.72 | -12.86% |
| S2 | ₹270.48 | -₹22.87 | -7.80% |
| S3 | ₹277.32 | -₹16.03 | -5.47% |
| S4 | ₹285.33 | -₹8.02 | -2.73% |
is trading CPR, indicating
CPR is
Day's range: ~
Trading Inside opening range
| Company Name |
|---|
Asian Paints Ltd |
Balaji Amines Ltd |
Camlin Fine Sciences Ltd |
Fineotex Chemical Ltd |
Foseco India Ltd |
Indigo Paints Ltd |
Jubilant Agri & Consumer Products Ltd |
Kiri Industries Ltd |
Laxmi Organic Industries Ltd |
Neogen Chemicals Ltd |
Rossari Biotech Ltd |
Raghav Productivity Enhancers Ltd |
S H Kelkar & Company Ltd |
Tatva Chintan Pharma Chem Ltd |
XPRO India Ltd |
Yasho Industries Ltd |

Advanced Enzyme Technologies Limited (AET) is a global company specializing in the research, development, manufacturing, and marketing of enzymes and probiotics. Their operations span across numerous countries including India, Europe, the United States, and other regions in Asia. AET's business model centers on providing high-quality enzyme and probiotic solutions to a diverse range of industries.
AET's product portfolio caters to a wide spectrum of applications. A significant portion of their business involves supplying enzymes and probiotics for the food and beverage industry. This includes applications in fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, dairy and cheese processing, and oils and fats processing. They also offer specialized enzyme solutions for applications in biofuels and bio-catalysis.
Beyond the food industry, AET provides enzymes for non-food processing applications. These include enzymes used in the textile, leather, and pulp and paper industries. Furthermore, their products are utilized in the formulation of detergents and cleaning aids. In the healthcare sector, AET offers enzyme and probiotic-based nutritional supplements targeted at both human and animal health markets.
The company's history dates back to 1957, originally operating under the name Advanced Biochemicals Limited. In 2005, the company rebranded as Advanced Enzyme Technologies Limited, reflecting its focus on enzyme technology. Headquartered in Thane, India, AET has established a global presence, supplying its products and services to international markets. Their continued success hinges on ongoing research and development, allowing them to expand their product offerings and adapt to the evolving needs of their diverse customer base.
5th Floor, 'A' wing, Sun Magnetica, LIC Service Road, Louiswadi, Thane (W)
Thane
MAHARASHTRA
IN
Tel: 912241703200
Website:https://www.advancedenzymes.com/
Group: Materials
Sector: Materials
Industry: Chemicals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 323
IPO Date: 01/08/2016
Mr. Vasant Rathi
Non-Executive Chairman of the Board
Mr. Beni Rauka
Chief Financial Officer
Mr. Dipak Roda
Senior Vice President - Business Development, Marketing
Mr. Mukund Kabra
Whole Time Director
Ms. Martina Doering
Managing Director and Head Of Business Development, Evoxx Technologies GmbH, Germany
Mr. Harshad Doshi
Chief Financial Officer and Chief Operating Officer of the US Subsidiaries
Dr. Michael Puls
Managing Director and Head Of Research and Development, Evoxx Technologies GmbH, Germany
Mr. Sanjay Basantani
Company Secretary and Head Legal
Ms. Rasika Rathi
Non-Executive Director
Dr. Sunny Sharma
Non-Executive Director
Mr. Nitin Deshmukh
Independent Director
Mr. Vinodkumar Jajoo
Independent Director
Get answers to the most common questions about Advanced Enzyme Technologies Ltd stock price, fundamentals, financial metrics, and investment analysis